Both in Biotechnology
Editas Medicine vs C4 Therapeutics
Over the past year EDIT returned −26.4% and CCCC returned +40.4%; their daily moves had a correlation of 0.39.
EDIT −26.4% CCCC +40.4%Growth of $1, one year, split-adjusted
| Metric | EDIT | CCCC |
|---|---|---|
| Price | $2.59 | $3.13 |
| Market cap | $397.8M | $385.1M |
| Today | +3.19% | +0.48% |
| 1 month | −18.0% | −18.7% |
| 6 months | +16.1% | +33.2% |
| Year to date | +26.3% | +63.9% |
| 1 year | −20.1% | +40.4% |
| Revenue growth (YoY) | +232.3% | +2.8% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −153.3% | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | 8.5× | 11.0× |
| Net cash | $155.9M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 69.7% | 54.0% |
| Short % of float | 20.1% | 40.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).